Abstract:In patients with Parkinson’s disease (PD), cognitive impairment is common and substantially exacerbates disease severity. The objective of this study is to investigate whether cognitive decline affects disease severity and whether structural network disruption contributes to cognitive impairment in PD patients. PD patients (n = 146) receiving structural and functional magnetic resonance imaging from Parkinson’s Progression Markers Initiative (PPMI) database were included. Based on the scores of Symbol Digit Modalities Test (SDMT), patients were classified into lower quartile group (SDMT score rank: 0%∼25%), interquartile group (SDMT score rank: 26%∼75%), and upper quartile group (SDMT score rank: 76%∼100%) according to their SDMT score quartiles to assess how cognitive function shapes disease manifestations and brain network topology. Patients in the lower quartile group exhibited more severe motor symptoms, non-motor symptoms, and striatal dopamine depletion compared to interquartile group and upper quartile group. In addition, they also showed impaired structural network topology both at global and local levels compared to interquartile group and upper quartile group. Furthermore, different nodal network metrics in structural network contributed to cognitive and motor impairment of PD patients. Taken together, PD patients with worse cognitive function exhibited more severe motor and non-motor symptoms and aberrant structural network metrics were associated with both cognitive and motor decline of PD patients. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from National Natural Science Foundation of China (Grant No. 81873778, 82071415) and National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (Grant No. NRCTM(SH)-2021-03). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The procedures of PPMI study have been approved by the Institutional Review boards of each participating center, and all patients signed informed consents before participating the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes

Changes of brain structure and structural covariance networks in Parkinson's disease associated cognitive impairment

Changes of Brain Structural Network Connection in Parkinson’s Disease Patients with Mild Cognitive Dysfunction: a Study Based on Diffusion Tensor Imaging

Microstructural but not macrostructural cortical degeneration occurs in Parkinson’s disease with mild cognitive impairment

Changes of Brain Structure in Parkinson’s Disease Patients with Mild Cognitive Impairment Analyzed Via VBM Technology

Locus Coeruleus Degeneration is Associated with Disorganized Functional Topology in Parkinson’s Disease

Brain Functional Network Abnormalities in Parkinson’s Disease with Mild Cognitive Impairment

Structural network topology correlates with cognitive impairment in Parkinson’s disease

Impaired topographic organization in Parkinson's disease with mild cognitive impairment

Characterization of cortical volume and whole-brain functional connectivity in Parkinson's disease patients: a MRI study combined with physiological aging brain changes

Alterations of regional homogeneity in Parkinson’s disease with mild cognitive impairment: a preliminary resting-state fMRI study

Mild Cognitive Impairment in Patients with Parkinson's Disease: A Voxel-Based Morphometry Analysis of Gray Matter

Brain networks and cognitive impairment in Parkinson’s disease

Structural Covariance Network Disruption and Functional Compensation in Parkinson's Disease.

Topologically Convergent and Divergent Morphological Gray Matter Networks in Early-Stage Parkinson's Disease with and Without Mild Cognitive Impairment

Diffusion Tensor Imaging Reveals White Matter Changes Associated with Cognitive Status in Patients with Parkinson's Disease.

Altered Cerebellar Resting-State Functional Connectivity in Early-Stage Parkinson's Disease Patients With Cognitive Impairment

Impaired Topological Architecture of Brain Structural Networks in Idiopathic Parkinson’s Disease: a DTI Study

Abnormalities in Structural Covariance of Cortical Gyrification in Parkinson's Disease

Structural and Functional Thalamic Changes in Parkinson's Disease with Mild Cognitive Impairment.

Aberrant Voxel-Based Degree Centrality in Parkinson's Disease Patients with Mild Cognitive Impairment.

Aberrant voxel-based degree centrality in Parkinson’s disease patients with mild cognitive impairment